CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma
Open Access
- 20 April 2026
- journal article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 16 (4) , e70672
Abstract
No abstract availableKeywords
Funding Information
- Cancerfonden (19 0098 PT)
- Cancerfonden (21 1808 Pj)
- Japan Society for the Promotion of Science (23K15554)
- Japan Society for the Promotion of Science (19H03745)
- Vetenskapsrådet (2018‐03086)
This publication has 8 references indexed in Scilit:
- FHL2 expression by cancer‐associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinomaInternational Journal of Cancer, 2024
- The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathwayNeoplasma, 2024
- Characterization and verification of CD81 as a potential target in lung squamous cell carcinomaBiochemical and Biophysical Research Communications, 2023
- The molecular mechanism of CD81 antibody inhibition of metastasisProceedings of the National Academy of Sciences, 2023
- Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell MigrationBiomolecules, 2023
- Machine learning-assisted elucidation of CD81–CD44 interactions in promoting cancer stemness and extracellular vesicle integrityeLife, 2022
- Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin PathwayMedical Science Monitor, 2019
- CD81 as a tumor targetBiochemical Society Transactions, 2017